Invasive Ductal Carcinoma

One of the most common types of breast cancer is invasive ductal carcinoma (IDC). This type of cancer develops in the milk ducts of the breast and can spread beyond the ducts into nearby tissues. IDC accounts for about 80% of breast cancer cases. IDC can manifest as a lump or thickening in the breast tissue or an abnormal mammogram or ultrasound shows signs of a mass. It can also cause changes in the texture or shape of the breast, as well as discharge from the nipple. Early detection of IDC is crucial for successful treatment. Standard therapies include surgical removal of the tumor, radiation therapy, and chemotherapy, depending on the size and spread of the cancer. Hormone therapy can be used if the cancer cells contain receptors for estrogen or progesterone. Research in hematology and oncology for IDC is focused on improving the diagnosis and treatment of this type of cancer. This includes the development of new biomarkers that can predict the likelihood of cancer recurrence, as well as the identification of new drugs and therapies that can target specific genetic mutations associated with IDC. It is important for women to be aware of their breast health and to have regular check-ups and mammograms, as early detection of IDC can greatly improve the chances for successful treatment and recovery.